Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

33%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph not_applicable

38%

Ph phase_2

25%

Ph phase_1

13%

Ph phase_3

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

1(14.3%)

Phase 2Efficacy & side effects

2(28.6%)

Phase 3Large-scale testing

1(14.3%)

N/ANon-phased studies

3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(2)

Detailed Status

Completed6

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (14.3%)

Phase 22 (28.6%)

Phase 31 (14.3%)

N/A3 (42.9%)

Trials by Status

terminated113%

withdrawn113%

completed675%

Recent Activity

0 active trials

Showing 5 of 8

terminatedphase_2

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

NCT02700841

withdrawnphase_2

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

NCT00008866

completed

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

NCT02747407

completednot_applicable

A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

NCT00000943

completedphase_1

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

NCT02109354

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT02700841Phase 2

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Terminated

NCT00008866Phase 2

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Withdrawn

NCT02747407

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Completed

NCT00000943Not Applicable

A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

Completed

NCT02109354Phase 1

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

Completed

NCT01559597Not Applicable

Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain

Completed

NCT01199861Phase 3

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Completed

NCT00001119Not Applicable

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Completed

All 8 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 8